image
Intellia Therapeutics, Inc. NTLA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 13.97
-7.61 %
$ 1.42 B
Market Cap
-2.56
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -30.40% 1.84% -12.47%
Annual Report FY 10-K 2022-12-31 57.69% -88.75% -71.05%
Annual Report FY 10-K 2021-12-31 -43.01% -106.83% -96.11%
Annual Report FY 10-K 2020-12-31 34.55% -35.46% -28.41%
Annual Report FY 10-K 2019-12-31 41.63% -8.62% -17.06%
Annual Report FY 10-K 2018-12-31 16.53% -26.35% -30.64%
Annual Report FY 10-K 2017-12-31 58.49% -113.51% -116.28%
Annual Report FY 10-K 2016-12-31 172.65% -155.17% -139.83%
Annual Report FY 10-K 2015-12-31 0.00% 13.36% -156.58%
Annual Report FY 10-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -24.02% -11.04% -10.42%
Quarterly Report Q2 8-K 2024-06-30 -48.82% -18.83% -5.07%
Quarterly Report Q1 8-K 2024-03-31 129.53% -16.34% -1.83%
Quarterly Report Q4 8-K 2023-12-31 -14.12% -13.22% -27.07%
Quarterly Report Q3 8-K 2023-09-30 -9.60% -7.94% -24.24%
Quarterly Report Q2 8-K 2023-06-30 -3.11% -23.71% -34.62%
Quarterly Report Q1 8-K 2023-03-31 12.03% 37.13% 22.38%
Quarterly Report Q4 8-K 2022-12-31 5.59% -43.69% -36.90%
Quarterly Report Q3 8-K 2022-09-30 84.15% -58.04% -46.58%
Quarterly Report Q2 8-K 2022-06-30 114.20% -45.30% -42.43%
Quarterly Report Q1 8-K 2022-03-31 74.58% -217.87% -210.71%
Quarterly Report Q4 8-K 2021-12-31 94.91% -92.54% -89.66%
Quarterly Report Q3 8-K 2021-09-30 -67.58% -157.34% -156.18%
Quarterly Report Q2 8-K 2021-06-30 -59.72% -112.41% -108.93%
Quarterly Report Q1 8-K 2021-03-31 -50.10% -45.27% -40.48%
Quarterly Report Q4 8-K 2020-12-31 -39.69% -49.21% -42.42%
Quarterly Report Q3 8-K 2020-09-30 109.31% -17.80% -10.95%
Quarterly Report Q2 8-K 2020-06-30 46.28% -26.13% -20.30%
Quarterly Report Q1 8-K 2020-03-31 23.80% -44.97% -38.80%
Quarterly Report Q4 8-K 2019-12-31 38.78% -48.31% -43.50%
Quarterly Report Q3 8-K 2019-09-30 43.30% -4.11% -5.10%
Quarterly Report Q2 8-K 2019-06-30 44.82% -15.59% -16.38%
Quarterly Report Q1 8-K 2019-03-31 39.68% -2.73% -6.15%
Quarterly Report Q4 8-K 2018-12-31 18.18% 20.44% 16.06%
Quarterly Report Q3 8-K 2018-09-30 1.24% -47.84% -51.80%
Quarterly Report Q2 8-K 2018-06-30 29.74% -42.49% -47.31%
Quarterly Report Q1 8-K 2018-03-31 20.18% -69.08% -73.23%
Quarterly Report Q4 8-K 2017-12-31 18.50% -126.86% -128.38%
Quarterly Report Q3 8-K 2017-09-30 50.28% -105.24% -106.25%
Quarterly Report Q2 8-K 2017-06-30 40.68% -125.99% -130.59%
Quarterly Report Q1 8-K 2017-03-31 249.75% -88.83% -93.43%
Quarterly Report Q4 8-K 2016-12-31 232.37% -101.39% -97.09%
Quarterly Report Q3 8-K 2016-09-30 188.45% -147.83% -133.17%
Quarterly Report Q2 8-K 2016-06-30 205.45% -126.97% -102.98%
Quarterly Report Q1 8-K 2016-03-31 38.18% -511.99% -460.17%
Quarterly Report Q4 8-K 2015-12-31 0.00% 27.32% -31.08%
Quarterly Report Q3 8-K 2015-09-30 0.00% -1596.07% -1754.49%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%